121 related articles for article (PubMed ID: 16632357)
1. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.
Wilkening RR; Ratcliffe RW; Tynebor EC; Wildonger KJ; Fried AK; Hammond ML; Mosley RT; Fitzgerald PM; Sharma N; McKeever BM; Nilsson S; Carlquist M; Thorsell A; Locco L; Katz R; Frisch K; Birzin ET; Wilkinson HA; Mitra S; Cai S; Hayes EC; Schaeffer JM; Rohrer SP
Bioorg Med Chem Lett; 2006 Jul; 16(13):3489-94. PubMed ID: 16632357
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta-subtype selective tetrahydrofluorenones: use of a fused pyrazole as a phenol bioisostere.
Wilkening RR; Ratcliffe RW; Fried AK; Meng D; Sun W; Colwell L; Lambert S; Greenlee M; Nilsson S; Thorsell A; Mojena M; Tudela C; Frisch K; Chan W; Birzin ET; Rohrer SP; Hammond ML
Bioorg Med Chem Lett; 2006 Aug; 16(15):3896-901. PubMed ID: 16730987
[TBL] [Abstract][Full Text] [Related]
3. A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies.
Kinzel O; Fattori D; Muraglia E; Gallinari P; Nardi MC; Paolini C; Roscilli G; Toniatti C; Gonzalez Paz O; Laufer R; Lahm A; Tramontano A; Cortese R; De Francesco R; Ciliberto G; Koch U
J Med Chem; 2006 Sep; 49(18):5404-7. PubMed ID: 16942012
[TBL] [Abstract][Full Text] [Related]
4. Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists.
Parker DL; Meng D; Ratcliffe RW; Wilkening RR; Sperbeck DM; Greenlee ML; Colwell LF; Lambert S; Birzin ET; Frisch K; Rohrer SP; Nilsson S; Thorsell AG; Hammond ML
Bioorg Med Chem Lett; 2006 Sep; 16(17):4652-6. PubMed ID: 16777408
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of estrogen receptor-beta selective ligands.
Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydrofluorenones with conformationally restricted side chains as selective estrogen receptor beta ligands.
Wildonger KJ; Ratcliffe RW; Mosley RT; Hammond ML; Birzin ET; Rohrer SP
Bioorg Med Chem Lett; 2006 Sep; 16(17):4462-6. PubMed ID: 16815012
[TBL] [Abstract][Full Text] [Related]
9. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
10. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
[TBL] [Abstract][Full Text] [Related]
14. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands.
Wolohan P; Reichert DE
J Mol Graph Model; 2004 Sep; 23(1):23-38. PubMed ID: 15331051
[TBL] [Abstract][Full Text] [Related]
15. Androstenediol analogs as ER-beta-selective SERMs.
Blizzard TA; Gude C; Morgan JD; Chan W; Birzin ET; Mojena M; Tudela C; Chen F; Knecht K; Su Q; Kraker B; Mosley RT; Holmes MA; Sharma N; Fitzgerald PM; Rohrer SP; Hammond ML
Bioorg Med Chem Lett; 2006 Feb; 16(4):834-8. PubMed ID: 16309907
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
Eignerová B; Sedlák D; Dracínský M; Bartunek P; Kotora M
J Med Chem; 2010 Oct; 53(19):6947-53. PubMed ID: 20812681
[TBL] [Abstract][Full Text] [Related]
17. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
[TBL] [Abstract][Full Text] [Related]
18. Indazole estrogens: highly selective ligands for the estrogen receptor beta.
De Angelis M; Stossi F; Carlson KA; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2005 Feb; 48(4):1132-44. PubMed ID: 15715479
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.
McDevitt RE; Malamas MS; Manas ES; Unwalla RJ; Xu ZB; Miller CP; Harris HA
Bioorg Med Chem Lett; 2005 Jun; 15(12):3137-42. PubMed ID: 15876535
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
